Exchange: NASDAQ·Updated 07:53 PM EST

About IMTX

About

Immatics NV is a clinical stage biopharmaceutical company, which engages in the research and development of T cell receptor-based immunotherapies for the treatment of cancer. Its pipeline includes adoptive cell therapy and TCR Bispecifics. The company was founded on March 10, 2020, and is headquartered in Tuebingen, Germany.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
656

Frequently Asked Questions

Advertisement|Remove ads.